Clinical Trial Update: A Phase 1 Study of PV-001 9-valent Human Papillomavirus(HPV) Vaccine [Phase 1]

View source ↗

Summary

POSVAX reports the completion of a Phase 1 study evaluating PV-001 9-valent HPV vaccine for human papillomavirus infections. The update indicates the trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• PV-001 9-valent HPV vaccine

Snippet

Sponsor: POSVAX | Conditions: HPV Infections | Phase 1 | Status: COMPLETED